Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
| Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
|---|---|---|---|---|
| Grassi C et al. | 2004 | intact cell/cell culture, human neuroblastoma cell line (IMR 32) and rat pituitary (GH3) cell line | magnetic field, low frequency, 50/60 Hz, co-exposure | 200–500 µT |
| Greene JJ et al. | 1991 | intact cell/cell culture, HL-60 cells (human acute myeloid leukaemia cell line) | electric field, magnetic field, 50/60 Hz | 1 mT |
| Greene JJ et al. | 1993 | intact cell/cell culture, HL-60 cells (human acute myeloid leukaemia cell line) | magnetic field, 50/60 Hz | 1 mT |
| Guo Y et al. | 2023 | animal, zebrafish (<i>Danio rerio</i>) | magnetic field, 50/60 Hz | - |
| Haghighat N et al. | 2017 | - | magnetic field, 50/60 Hz, co-exposure, also other exposures without EMF | - |
| Harrison GH et al. | 1997 | intact cell/cell culture, A172 (human glioblastoma cells), MCF7 WT(human breast cancer cell line) and HeLa S3 (human cervical carcinoma cell line) | magnetic field, 50/60 Hz | 2 mT |
| Hasanzadeh H et al. | 2014 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | magnetic field, 50/60 Hz | 2 mT |
| Heidari S et al. | 2021 | intact cell/cell culture, human adenocarcinoma gastric cancer cell line (AGS) | 50/60 Hz, magnetic field | 0.2–2 mT |
| Hemmati M et al. | 2014 | animal, mouse/Balb/c (embryo), whole body: <i>in utero</i> | magnetic field, 50/60 Hz | 0.5 mT |
| Henderson B et al. | 2006 | intact cell/cell culture, human umbilical venous endothelial cells | magnetic field, 50/60 Hz | 10–700 µT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.
